Dr. Clark received formal medical training in clinical medicine with a focus on metabolic and regenerative health, spending over 10 years in medical education and research-based writing. He specializes in translating complex clinical studies into clear, practical information on research peptides, recovery, energy balance, and healthy aging.
Dr. Clark focuses on metabolic and regenerative medicine and research peptides, with clinical interests centered on improving overall health through targeted, modern therapeutic approaches. He does not promote and is strictly against the use of unapproved medicine or peptides for human use.
Dr. Clark focuses on clear and simple patient education, believing medical information should be easy to understand and practical to use. His writing breaks down complex clinical research into simple explanations so readers can make informed decisions about their health.
Explore the latest research-based articles written by Dr. Clark.
BPC-157, widely known in peptide circles as the “Wolverine peptide,” has become part of a growing U.S. debate over access to unapproved peptides. U.S. Health
GHK-Cu and AHK-Cu are two copper-binding tripeptides. They are closely related, but they are not the same compound and should not be treated as interchangeable
Choosing a research peptide supplier should involve more than comparing prices or advertised purity percentages. Before placing an order, researchers should review batch-specific testing, peptide
This site supplies research compounds strictly for laboratory research. You must confirm both statements below to enter.
Compounds are supplied for laboratory research use only and are not for human or veterinary use.
